API5 and prostate carcinoma: These data suggest regulatory mechanisms whereby tumors with low miR-203 output, have an increase in EGFR ligands (EREG and TGFA) and anti-apoptotic proteins (API5, BIRC2, and TRIAP1) expression, resulting in prostate cancer bone metastasis and TKIs resistance.